Tanguler Tolga sold ALNY

February 13, 2026 · Form 4 insider transaction

Tanguler Tolga sold 1,959 shares of Alnylam Pharmaceuticals, Inc. at $310.08 per share, a transaction worth $607.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,959
Price
$310.08
Total value
$607.4K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after31,769
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations.; The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $302.55 to $314.60. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

View the original Form 4 on SEC EDGAR
Tanguler Tolga sold ALNY: February 13, 2026 | Insider Trading Screener